7岁男孩患有m.3251A>G MT-TL1突变的渐进性肌肉病和呼吸衰竭
Daria Hoang1, Alan Pestronk2, Jafar Kafaie1,3,4
1Department of Neurology, Saint Louis University School of Medicine, St. Louis, MO.
Journal of clinical neuromuscular disease
|March 2, 2026
概括
一种罕见的MT-TL1基因变异在儿童中引起严重的线粒体肌肉病变. 用线粒体辅助因子治疗改善了他的病情,突出了与炎症性肌肉病变的差异.
科学领域:
- 遗传学 是一个遗传学.
- 神经学 神经学
- 儿科 儿科 儿科
背景情况:
- 线粒体肌肉病是一种衰弱的神经肌肉疾病.
- 罕见的遗传变异可能导致严重的儿科病例.
- 区分线粒体和炎症性肌肉病是有效治疗的关键.
研究的目的:
- 报告一个患有严重孤立线粒体肌肉病变的儿科病例.
- 为了确定遗传原因,MT-TL1基因中的m.3251A>G变异.
- 讨论临床和组织病理学特征以及治疗反应.
主要方法:
- 一个7岁男孩的临床表现和诊断工作.
- 组织病理学发现的肌肉活检分析.
- 基因检测用于识别线粒体DNA变异.
- 用类固醇,免疫球蛋白和线粒体辅因子治疗的反应.
主要成果:
- 患者出现了急性-慢性衰弱和呼吸系统不充分.
- 肌肉活检显示了破碎的红色纤维和线粒体增殖,没有炎症.
- 基因测试证实MT-TL1基因中的m.3251A>G变异.
- 停止免疫抑制剂和启动线粒体辅因子导致临床改善.
结论:
- 在MT-TL1中的m.3251A>G变体可以导致儿童严重的孤立线粒体肌肉病变.
- 组织病理学发现和临床过程将这种病例与炎症性肌肉病变区分开来.
- 线粒体辅因子疗法在这个儿科线粒体肌肉病症病例中显示出有效性.
相关概念视频
Acute Respiratory Failure-III
1.0K
Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without...
1.0K
Myasthenia Gravis: Overview and Treatment
3.2K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
3.2K
Cystic Fibrosis: Pathogenesis
954
Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
954
Myasthenia Gravis: Diagnostic Tests
2.9K
Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
2.9K
Cystic Fibrosis: Management
588
Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic...
Sinus disease and chronic...
588
Satellite Stem Cells and Muscular Dystrophy
2.5K
Satellite stem cells or myosatellite cells are quiescent stem cells that Alexander Mauro first identified in 1961. These cells are located between the sarcolemma, the plasma membrane of muscle fibers, and the basal lamina, the connective tissue sheath covering it. These mononucleated cells are activated in response to muscle injury, can transform into myoblasts, and may form or repair muscle fibers. Myosatellite cells can provide additional myonuclei for muscle regeneration or return to a...
2.5K


